Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.4800
-0.0200 (-4.00%)
Oct 6, 2025, 9:30 AM EDT
-4.00%
Market Cap36.75M
Revenue (ttm)10.88K
Net Income (ttm)-4.01M
Shares Out76.57M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume500
Average Volume1,175
Open0.4800
Previous Close0.5000
Day's Range0.4800 - 0.4800
52-Week Range0.2800 - 1.2500
Beta0.22
RSI43.49
Earnings DateNov 28, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.